Treating Inflammatory Bowel Disease by Enhancing HNF-4a Activity.

Interface Between Antigen-Presenting Cells, Lympahtics, and the Expansion of Adipose Tissue in Inflammatory Intestinal Disease.

Identification of Microbial Triggers of Colitis in Genetically Relevant, Transmissible Mouse Model.

Bioengineering Bacterially Derived Immunomodulants: A Novel Therapeutic Approach to IBD.

Harnessing Immuno-nanotechnology for Therapy of Inflammatory Bowel Disease.

Epigenetic Control of Intestinal Inflammation.

Is Restricted Expression of TLR5 in the Small Intestine Necessary to Limit Responses to Commensal Bacteria?

Novel Adhesive Interactions Modulate T Cell Responses In IBD.

From Newborn Immunity To Adult IBD.

The Role Of Long Non-Coding RNA, LincRNA-Eps In Controlling Gut Inflammation.